Journals / Annals of Medical Research / 2018 / Cilt: 25 - Sayı: 4

A retrospective study on the effects of diabetes mellitus on perioperative fibrinogen and bleeding amount in coronary artery bypass surgery patients

Pages
643–647
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Postoperative bleeding amount, erythrocyte, and fibrinogen transfusion need were found to be significantly lower in Group D compared to Group C (p = 0.04, p = 0.01, and p< 0.001, respectively).Conclusion: Diabetic patients had decreased amount ofpostoperative bleeding, possibly due to a thrombotic tendency caused by chronic inflammation related to diabetes mellitus.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, the effects of changes in the coagulation system of diabetic patients that undergo heart surgery on postoperative bleeding amount and complications was investigated.Material and Methods: A total of 106 patients (35 females, 71 males) were retrospectively examined in the study.
📊
Key Findings & Data:Patients were divided into two groups: diabetic (Group D, n = 47) and non-diabetic (Group C, n = 59).
💡
Conclusion & Impact:Postoperative bleeding amount, erythrocyte, and fibrinogen transfusion need were found to be significantly lower in Group D compared to Group C (p = 0.04, p = 0.01, and p< 0.001, respectively).Conclusion: Diabetic patients had decreased amount ofpostoperative bleeding, possibly due to a thrombotic tendency caused by chronic inflammation related to diabetes mellitus.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: In this study, the effects of changes in the coagulation system of diabetic patients that undergo heart surgery on postoperative bleeding amount and complications was investigated.Material and Methods: A total of 106 patients (35 females, 71 males) were retrospectively examined in the study. Patients were divided into two groups: diabetic (Group D, n = 47) and non-diabetic (Group C, n = 59). Preoperative and postoperative hematologic values, postoperative bleeding, and transfusion amounts of all groups were recorded.Results: Preoperative and postoperative fibrinogen and C-reactive protein (CRP) values in Group D were significantly higher compared to those in Group C (p< 0.05 and p< 0.01, respectively). Postoperative bleeding amount, erythrocyte, and fibrinogen transfusion need were found to be significantly lower in Group D compared to Group C (p = 0.04, p = 0.01, and p< 0.001, respectively).Conclusion: Diabetic patients had decreased amount ofpostoperative bleeding, possibly due to a thrombotic tendency caused by chronic inflammation related to diabetes mellitus.

🔖

Cite This Article

TUĞCUGİL, E., BEŞİR, A., SEN, A., ERDİVANLI, B. (2022). A retrospective study on the effects of diabetes mellitus on perioperative fibrinogen and bleeding amount in coronary artery bypass surgery patients. Annals of Medical Research, Cilt: 25 - Sayı: 4, 643–647. https://ajindex.com/articles/447354

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hartmann M, Sucker C, Boehm O, et al. Efeects of cardiac surgery on hemostasis. Transfus Med Rev 2006;20:230-41. Waldén K, Jeppsson A, Nasic S, et al. Low preoperative fibrinogen plasma concentration is associated with excessive bleeding after cardiac operations. Ann Thorac Surg 2014;97:1199-206. Rich JB. The efficacy and safety of aprotinin use in cardiac surgery. Ann Thorac Surg 1998;66:6-11.
  2. Ranucci M, Baryshnikova E, Castelvecchio S, et al. Surgical and Clinical Outcome Research (SCORE) Group. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg 2013;96:478-85.
  3. Levy JH, Dutton RP, Hemphill III JC, et al. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 2010;110:354-64.
  4. Kubal C, Srinivasan AK, Grayson AD, et al.Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery. Ann Thorac Surg 2005;79:1570-76.
  5. Feng Jun MD, Frank W Sellke M. Microvascular dysfunction in patients with diabetes after cardioplegic arrest and cardiopulmonary bypass. Curr Opin Cardiol 2016;31: 618–24.
  6. Potz BA, Scrimgeour LA, Feng J, et al. Diabetes and Cardioplegia. J Nat Sci 2017;3:394:1-6.
  7. Pomero F, Di Minno MN, Fenoglio L, et al. Is diabetes a hypercoagulable state? A critical appraisal. Acta Diabetol 2015;52:1007-16. Nomura S. Dynamic role of microparticles in type 2 diabetes mellitus. Curr Diabetes Rev 2009;5:245–51.
  8. Gielen C, Dekkers O, Stijnen T, et al. The effects of pre- and postoperative fibrinogen levels on blood loss after cardiac surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 2014;18: 292-8.
  9. Camila Takao Lopes, Talita Raquel Dos Santos, Evelise Helena Fadini Reis Brunori, et al. Excessive bleeding predictors after cardiac surgery in adults: integrative review. Clin Nurs 2015;24:046–62.
  10. Rafiq S, Johansson PI, Ostrowski SR, et al. Hypercoagulability in patients undergoing coronary artery bypass grafting: Prevalence, patient characteristics and postoperative outcome. Eur J Cardiothorac Surg 2012;41:550-5.
  11. Bochsen L, Nielsen AB, Steinbrüchel DA, Johansson PI. Higher thromboelastograph platelet reactivity in cardiac surgery patients than in blood donors, Scand Cardiovascular J 2007; 41: 321-4.
  12. Sato H, Carvalho G, Sato T. The Association of Preoperative Glycemic Control, Intraoperative Insulin Sensitivity, and Outcomes after Cardiac Surgery, J Clin Endocrinol Metab 2010;95:4338-44.
  13. Kristensen KL, Rauer LJ, Mortensen PE, et al. Reoperation for